Closing the care gap.
Periwell was born from a simple, frustrating truth: women are being dismissed during their most significant health transition.

A Letter from our Founder
“I was 43 when the ‘3 AM light switch’ started. Then came the brain fog, the sudden rage, and the bone-deep fatigue. My doctor told me I was ‘just stressed’.
Three years and five doctors later, I finally learned it was perimenopause. But I also learned that my story wasn't unique. Millions of women are suffering through this transition without objective data or clinical support.
We built Periwell to change that. Not just to track symptoms, but to provide the intelligence needed to walk into a clinic and finally be heard.”
— Elena Rossi, Founder of Periwell
Our Journey
Periwell founded after Elena's 5-year diagnosis journey
Clinical framework validated against STRAW+10 & NAMS guidelines
10,000 women joined during early access beta
Clinician Report launched; Provider Directory goes live
12,000+ active users across 28 countries
The Team Behind Periwell
Elena Rossi
Founder & CEO
Former product lead at a digital health company, Elena began building Periwell after her own 3-year misdiagnosis journey through perimenopause.
Dr. Meera Patel
Clinical Advisor · OB/GYN
Board-certified OB/GYN with 18 years of experience in reproductive endocrinology. Oversees Periwell's clinical framework and report standards.
Dr. Soo-Yeon Kim
Research Advisor · Endocrinology
Research faculty with expertise in the STRAW+10 staging system and hormonal biomarkers. Validates Periwell's scoring methodology.
Our Commitment
- Clinical Integrity: We strictly follow STRAW+10 and NAMS guidelines.
- Privacy First: Your data is yours. We aren't an ad product.
- Accessibility: Core symptom intelligence will always be free.
Our Vision
We see a world where perimenopause is treated with the same clinical rigor as any other major health transition. A world where ‘being dismissed’ is a thing of the past.
Join the transition
Be part of the 12,000+ women reclaiming their health through data.